Lexeo was referred to us by Longitude Capital in 2021, during their preparation for Series B financing. They needed practical guidance to distill clear messaging and build a compelling corporate story for upcoming investor meetings.

We followed our typical process, which involved diving deep into their scientific concepts, reviewing their materials, and conducting interviews with their executive team. From there, we crafted a comprehensive strategy, including clear positioning and messaging, coupled with simple graphics and scientific illustrations to create a persuasive investor presentation and corporate website.

Our strategy highlighted LEXEO’s programs and business objectives, leading to a successful Series B round raising $100M.

We’ve been working with Lexeo ever since, and one of their latest requests was to help them create a patient recruitment site that explains gene therapy in a clear, illustrative way. We’ve created a website using illustrations and simple language to help them connect with patients.